EC

EcoR1 Capital Portfolio holdings

AUM $1.69B
This Quarter Return
-11.3%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$957M
AUM Growth
+$957M
Cap. Flow
+$74.6M
Cap. Flow %
7.79%
Top 10 Hldgs %
58.48%
Holding
64
New
21
Increased
9
Reduced
14
Closed
12

Top Buys

1
FATE icon
Fate Therapeutics
FATE
$42M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$22.5M
3
PBYI icon
Puma Biotechnology
PBYI
$21.4M
4
ANAB icon
AnaptysBio
ANAB
$15.1M
5
SGMO icon
Sangamo Therapeutics
SGMO
$14.7M

Top Sells

1
ARGX icon
argenx
ARGX
$32.4M
2
FGEN icon
FibroGen
FGEN
$21.2M
3
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
$13.4M
4
SAGE
Sage Therapeutics
SAGE
$12.5M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
$7.44M

Sector Composition

1 Healthcare 92.25%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CTMX icon
51
CytomX Therapeutics
CTMX
$336M
$8K ﹤0.01% 1,101 -408,899 -100% -$2.97M
ARGX icon
52
argenx
ARGX
$43.6B
– – -202,117 Closed -$32.4M
BMRN icon
53
BioMarin Pharmaceuticals
BMRN
$11.2B
– – 0 – –
EOLS icon
54
Evolus
EOLS
$494M
– – -600,000 Closed -$7.3M
IGMS
55
DELISTED
IGM Biosciences
IGMS
– – -100,000 Closed -$3.82M
IOVA icon
56
Iovance Biotherapeutics
IOVA
$807M
– – -213,647 Closed -$5.91M
SAGE
57
DELISTED
Sage Therapeutics
SAGE
– – -173,364 Closed -$12.5M
VCEL icon
58
Vericel Corp
VCEL
$1.83B
– – -131,001 Closed -$2.28M
XFOR icon
59
X4 Pharmaceuticals
XFOR
$84.3M
– – -415,400 Closed -$4.45M
EIGR
60
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
– – -449,338 Closed -$6.7M
HARP
61
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
– – -908,547 Closed -$13.4M
TCRR
62
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
– – -239,500 Closed -$3.42M
RUBY
63
DELISTED
Rubius Therapeutics, Inc
RUBY
– – -525,877 Closed -$5M
UROV
64
DELISTED
Urovant Sciences Ltd.
UROV
– – -26,468 Closed -$411K
1 2
3